Howard Berman

Insider Reports History

Entity
Individual
Location
C/O Coya Therapeutics, Inc., 5850 San Felipe St., Suite 500, Houston, TX
Signature
/s/ David Snyder, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Howard Berman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Coya Therapeutics, Inc. Chief Executive Officer, Director Stock Option (right to buy) 164K Jun 3, 2024 Direct

Insider Reports Filed by Howard Berman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
COYA Coya Therapeutics, Inc. Jun 3, 2024 1 $0 4 Jun 5, 2024 Chief Executive Officer, Director
COYA Coya Therapeutics, Inc. Jan 31, 2024 1 $0 4 Feb 2, 2024 Chief Executive Officer, Director
COYA Coya Therapeutics, Inc. Feb 27, 2023 1 $0 4 Mar 1, 2023 Chief Executive Officer, Director
COYA Coya Therapeutics, Inc. Jan 3, 2023 0 $0 4/A Jan 17, 2023 Chief Executive Officer, Director, 10%+ Owner
COYA Coya Therapeutics, Inc. Dec 28, 2022 0 $0 3 Dec 28, 2022 Chief Executive Officer, Director, 10%+ Owner